title: Response to letter regarding article, "Asymmetric dimethylarginine in response to recombinant tissue-type plasminogen activator and erythropoietin in acute stroke".
authors.affiliation: Department of Neurology, Hannover Medical School, Hannover, Germany.
authors.forename: Hans
authors.initials: H
authors.lastname: Worthmann
authors.forename: Jan T
authors.initials: JT
authors.lastname: Kielstein
authors.forename: Karin
authors.initials: K
authors.lastname: Weissenborn
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives*; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D004921:Erythropoietin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D020521:Stroke / Q000188:drug therapy* / Q000378:metabolism*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
chemical_list: D004921:Erythropoietin; D001120:Arginine; D010959:Tissue Plasminogen Activator